July 12 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published ...

Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes. Doctors say there may be ...

Diabetic study participants were less likely to develop cognitive deficits on Ozempic than other diabetes medications. Ozempic was also linked to a lower likelihood of smoking. The study found ...

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, sold as Ozempic and Wegovy, is linked with a significantly lower risk of dementia — possibly adding to ...

Novo Nordisk A/S’s Ozempic was linked to lower rates of dementia and a range of other mental problems in a University of Oxford study that raises expectations about the diabetes drug’s ...

Novo Nordisk A/S. NVO has found that its “miracle” weight loss drug used for diabetes, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues.

Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems ...

Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University. The study ...

NOVO Nordisk’s popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University. The study, ...